ALDX

Latest ALDX News

Stay updated with the latest market insights and press releases for ALDX

Is Aldeyra Therapeutics a mispriced gem amid FDA's setback for Reproxalap?

Aldeyra Therapeutics has experienced a dramatic turnaround. After a steep decline of over 75% due to an FDA request for more data on its flagship drug...

April 21, 2025

Why Aldeyra Therapeutics Could Be a Smart Speculative Bet Despite the Recent CRL Setback

A recent setback linked to CRL has sparked fresh debates about the future of Aldeyra Therapeutics. This update considers why some experts see the comp...

April 8, 2025